Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer.
Authors:
- Toshiaki TakahashiTTToshiaki Takahashi
- Nobuyuki YamamotoNYNobuyuki Yamamoto
- Toshihiro NukiwaTNToshihiro Nukiwa
- Kiyoshi MoriKMKiyoshi Mori
- Masahiro TsuboiMTMasahiro Tsuboi
- Takeshi HoraiTHTakeshi Horai
- Noriyuki MasudaNMNoriyuki Masuda
- Kenji EguchiKEKenji Eguchi
- Tetsuya MitsudomiTMTetsuya Mitsudomi
- Soichiro YokotaSYSoichiro Yokota
- Yoshihiko SegawaYSYoshihiko Segawa
- Yukito IchinoseYIYukito Ichinose
- 1 February 2010
- journal article
- research article
- Vol. 30 (2) , 557-63